Orchid Pharma Ltd. (ORCHPHARMA): Orchid Pharma Share Price Near 52-Week High on 2.61% Gain

Orchid Pharma Share Price is trading at Rs 1,132.45, up 2.61% today, and remains close to its 52-week high zone as of 24 September 2026 at 11:18 AM IST. The company’s market capitalisation stands at Rs 6,630.49 Cr, placing the move in a clearly defined market-cap context. Orchid Pharma Ltd. (ORCHPHARMA) is therefore one of the stocks in news in the Indian stock market today, with Orchid Pharma Share Price Today drawing attention because the price is holding near its yearly high. The latest Univest data confirms the price event, while the figures provided do not establish a company-specific catalyst. Investors tracking Orchid Pharma Stock News can also see that the move comes alongside valuation metrics, sector benchmarks and peer comparisons that help frame Orchid Pharma Share Price in a broader research context.

Orchid Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,132.45
Previous Close	Rs 1,103.65
Today's Move	+Rs 28.8 (+2.61%)
Open	Rs 1,097.9
High	Rs 1,140
Low	Rs 1,097
Turnover	Rs 0.66 crore
Market Capitalisation	Rs 6,630.49 crore

Orchid Pharma Ltd. (ORCHPHARMA) traded at Rs 1,132.45 versus the previous close of Rs 1,103.65, a rise of 2.61%. The stock opened at Rs 1,097.9, reached a high of Rs 1,140 and touched a low of Rs 1,097.

Orchid Pharma Share Price traded at Rs 1,132.45 versus the previous close of Rs 1,103.65, a gain of Rs 28.80 or 2.61%. The stock opened at Rs 1,097.90, moved between Rs 1,097 and Rs 1,140, and was last seen near the upper end of that range. Turnover stood at Rs 0.66 Cr, which is the verified traded-value measure for the move. On this price pattern, Orchid Pharma Share Price Today is trading close to its 52-week high, and the latest Univest figures confirm the event without assigning a cause. For readers following Orchid Pharma Share Price Live, the key fact is that price has stayed elevated relative to the prior close and the day’s lower levels.

Orchid Pharma Ltd. (ORCHPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,630.49 crore
P/E Ratio	762.66x
P/B Ratio	4.22x
ROE	0.7%
ROCE	1.11%
EPS	Rs 1.45
Book Value Per Share	Rs 261.65
Dividend Yield	0%

Orchid Pharma Ltd. (ORCHPHARMA) fundamental metrics show P/E 762.66x, P/B 4.22x, ROE 0.7%, ROCE 1.11%. These figures provide context only and are not a buy or sell signal.

Orchid Pharma Ltd. has a market capitalisation of Rs 6630.49 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 762.66x, P/B at 4.22x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 0.7% and ROCE of 1.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.45, book value per share of Rs 261.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.31x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	762.66x
Benchmark Median P/E	28.31x
Benchmark Average P/E	38.64x
Benchmark P/E Range	0x to 412.58x
Company P/B Ratio	4.22x
Benchmark Median P/B	2.9x
Company ROE	0.7%
Benchmark Median ROE	11.7%
Company ROCE	1.11%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 6,630.49 crore
Benchmark Median Market Cap	Rs 745.38 crore

Orchid Pharma Ltd. (ORCHPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 762.66x, which is above the benchmark median of 28.31x, a difference of +2,593.96%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Orchid Pharma Ltd. (ORCHPHARMA) has a ROE of 0.7%, which is below the benchmark median of 11.7%, a difference of -94.02%. Orchid Pharma Ltd. (ORCHPHARMA) has a ROCE of 1.11%, which is below the benchmark median of 13.61%, a difference of -91.84%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Morepen Laboratories Ltd.	MOREPENLAB	6,517.91	47.71	5.15	7.96	10.19
SENORES PHARMACEUTICALS L	SENORES	6,354.24	50.48	6.62	14.14	15.66
Innova Captab Ltd.	INNOVACAP	6,998.32	47.57	6.55	13.75	15.04
Sanofi India Ltd.	SANOFI	7,038.39	21.72	8.51	44.5	55.46
SYMBIOTEC PHARMALAB LTD	SYMBIOTEC	7,204.72	62.1	4.55	11.22	12.41

Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 762.66x compared with the displayed peer median of 47.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0.7% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 1.11% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Orchid Pharma Ltd. (ORCHPHARMA) has a market capitalisation of Rs 6,630.49 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Orchid Pharma

• Orchid Pharma Share Price is trading at Rs 1,132.45, up 2.61% from the previous close of Rs 1,103.65.
• The stock remains near its 52-week high zone, making Orchid Pharma Share Price Today a live market focus.
• Turnover stood at Rs 0.66 Cr, which is the verified traded-value figure for the move.
• Orchid Pharma Fundamental Analysis shows P/E of 762.66, P/B of 4.22, ROE of 0.7 and ROCE of 1.11.
• Orchid Pharma Share Price is being compared with a same-industry benchmark of 199 companies and peers in Healthcare.

About Orchid Pharma

Orchid Pharma Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. Orchid Pharma Share Price reflects market tracking of a listed pharma company with a market capitalisation of Rs 6,630.49 Cr on the NSE and BSE. Univest data places Orchid Pharma Stock News in a sector where valuation, earnings and returns on equity and capital are closely watched. The company’s latest financial figures include revenue and net profit data for recent reported periods, which are useful for reading Orchid Pharma Company News and Orchid Pharma Earnings in context.

Frequently Asked Questions

Why is Orchid Pharma Share Price in focus today?

Ans. Orchid Pharma Share Price is in focus because it is trading at Rs 1,132.45, up 2.61% from the previous close, and remains near its 52-week high zone as of 24 September 2026 at 11:18 AM IST.

What is Orchid Pharma Share Price today?

Ans. Orchid Pharma Share Price today is Rs 1,132.45. The stock moved from a previous close of Rs 1,103.65 and traded between Rs 1,097 and Rs 1,140 during the latest update.

How far is Orchid Pharma Share Price from its 52-week high?

Ans. Orchid Pharma Share Price is trading within its 52-week high zone. The latest market data confirms the near-high event, but no exact 52-week peak value was provided alongside the current quote.

What is the market capitalisation of Orchid Pharma?

Ans. Orchid Pharma has a market capitalisation of Rs 6,630.49 Cr. That places Orchid Pharma Share Price in a clearly defined listed-company size range within the Healthcare sector and Pharmaceuticals & Drugs industry.

What do Orchid Pharma’s valuation metrics show?

Ans. Orchid Pharma Share Price is paired with a P/E ratio of 762.66 and a P/B ratio of 4.22. EPS is Rs 1.45 and book value per share is Rs 261.65, which helps frame valuation context.

How do Orchid Pharma’s ROE and ROCE compare?

Ans. Orchid Pharma reports ROE of 0.7 and ROCE of 1.11. Both are below the same-industry benchmark medians of 11.7 and 13.61, making profitability efficiency a key comparison point for Orchid Pharma Share Price.

Does Orchid Pharma pay a dividend?

Ans. Orchid Pharma’s dividend yield is 0. For Orchid Pharma Share Price, that means the current cited data does not indicate a dividend income component, so valuation and earnings remain the main metrics.

How does Orchid Pharma compare with peers?

Ans. Orchid Pharma Share Price is compared with peers such as Morepen Laboratories, SENORES Pharmaceuticals and Sanofi India. Its market cap is close to some peers, while its P/E is much higher than the listed peer set.

Track Orchid Pharma Share Price on Univest

Use Orchid Pharma Ltd. (ORCHPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Orchid Pharma Share Price on Univest to follow live price updates, Orchid Pharma Share Price Today, company fundamentals, market cap, valuation ratios, sector context and peer comparison. Univest also helps users monitor Orchid Pharma Stock Analysis, Orchid Pharma Share Price Live, Orchid Pharma Share Price Update and Orchid Pharma Latest News in one place.